Publications by authors named "K Adu-Bonsaffoh"
Background: Most studies on respectful maternity care (RMC) and mistreatment of women have focused on intrapartum care with limited information on how women are treated during induction of labor (IOL), pre-labor phase of the maternity care continuum. Emerging multi-country evidence indicates that nearly 30% of women who undergo IOL do not consent to the procedure and constitutes a violation of their rights to optimal maternal health. This study explored women's lived experiences of respectful care and mistreatment during IOL in a tertiary setting in Ghana.
View Article and Find Full Text PDFArticle Synopsis
- Postpartum hemorrhage (PPH) is a leading cause of maternal mortality worldwide, and this study investigated the feasibility and acceptability of using heat-stable carbetocin (HSC) for prevention and tranexamic acid (TXA) for treatment in five Sub-Saharan African countries.
- Conducted between May and December 2022, the study involved a mixed methods approach, assessing the usage and healthcare providers' perceptions of these medications in facilities across Burkina Faso, Ethiopia, Ghana, Sierra Leone, and Uganda.
- Results showed high administration rates of HSC and TXA during appropriate times with no reported adverse events, indicating that these medicines can be safely and acceptably integrated into maternal care, although ongoing training and improved
Article Synopsis
- The study investigates the prevalence, complications, and management of ectopic pregnancy (EP) and molar pregnancy (MP) in selected healthcare facilities across 17 countries in Africa and Latin America and the Caribbean (LAC).
- Data were collected from 280 healthcare facilities, revealing that 9.9% of women had EP or MP, with EP having more severe complications compared to MP.
- Findings suggest a need for improving quality care for EP and MP, emphasizing the importance of evidence-based management practices to reduce maternal morbidity and mortality in these regions.
Globally, the incidence of hypertensive disorders of pregnancy, especially preeclampsia, remains high, particularly in low- and middle-income countries. The burden of adverse maternal and perinatal outcomes is particularly high for women who develop a hypertensive disorder remote from term (<34 weeks). In parallel, many women have a suboptimal experience of care.
View Article and Find Full Text PDFIntroduction: pre-eclampsia (PE) is a multisystemic pregnancy-specific hypertensive disorder associated with significant adverse maternal and perinatal outcomes. Maternal serum uric acid level is hypothesized as a reliable marker for predicting the severity and adverse outcomes of pre-eclampsia and facilitating clinical decisions. This study explored the association between maternal serum uric acid and adverse pregnancy outcomes in pre-eclampsia.
View Article and Find Full Text PDF